News

Opinion
Zacks Investment Research on MSN9hOpinion
Early Q2 Results Indicate an Improving Earnings Outlook
We get into the heart of the Q2 earnings season this week, with more than 400 companies on deck to report results, including 109 S&P 500 members. The reporting docket expands beyond the Finance core, ...
Pfizer (PFE) came out with quarterly earnings of $0.67 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $2.04 per share a year ago. These figures ...
Pfizer Inc. (NYSE:PFE) Q2 2024 Earnings Conference Call July 30, 2024 10:30 AM ETCompany ParticipantsFrancesca DeMartino – Chief Investor Relations Officer ...
Pfizer Inc. (PFE) reported Q2 FY 2022 earnings results that solidly surpassed analyst expectations. Adjusted earnings per share (EPS) surged by 92.5% relative to the year-ago quarter, beating ...
Pfizer Inc. (NYSE:PFE – Free Report) – Equities research analysts at Zacks Research reduced their Q2 2026 earnings per share (EPS) estimates for Pfizer in a report issued on Thursday, March ...
We think Pfizer’s top line will see growth in the low teens, driven by market share gains for Vyndaqel and Abrysvo.
With Pfizer’s sales rising in Q2, despite falling sales of Covid-19 products, we think that it may well be the turning point for Pfizer stock .
PFE’s FY24 Outlook Looking forward, Pfizer raised its FY24 forecast by $1 billion to be in the range of $59.5 billion to $62.5 billion and raised its adjusted earnings guidance by $0.30 to be ...
Pfizer Inc. (NYSE:PFE) Q2 2023 Results Conference Call August 1, 2023 10:00 AM ETCompany ParticipantsChris Stevo - SVP and Chief IR OfficerDr.
Pfizer's next earnings report (for Q2 FY 2022) is expected to be released on July 26, 2022. Do you have a news tip for Investopedia reporters? Please email us at ...